References
- The Canadian Multicenter Transplant study group. A randomized clinical trial of cyclosporine in cadaveric renal transplantation. New Engl J Med 1983; 309: 809–815
- Porter G. A., Bennett W. M. Chronic cyclosporine-associated nephrotoxicity. Transplant Proc 1986; 18: 204–207
- Burkle W. S. Cyclosporine pharmacokinetics and blood level monitoring. Drug Intell Clin Pharm 1985; 19: 101–105
- De Groen P. C., Aksamit A. J., Rakela J., Forbes G. S., Krom R. A. F. Central nervous system toxicity after liver transplantation. N Engl J Med 1987; 317: 861–866
- Luke D. R., Brunner L. J., Vadiei K. Cyclosporine pharmacokinetics and toxicity in the hyperlipidemic rat model. In press
- Yee G. C., Lennon T. P., Gmur D. J., Cheney C. L., Oeser D., Deeg H. J. Effect of obesity on cyclosporine disposition. Transplantation 1988; 45: 649–651
- Martin R. J., Stolz D. J., Buck D. C. Diurnal changes in adipose and liver tissue metabolism of lean and obese Zucker rats. J Nutr 1979; 109: 412–417
- Cipolle R. J., Canafax D. M., Rabitin J., Bowers L. D., Sutherland D. E. R., Hrushesky W. J. M. Time-dependent disposition of cyclosporine after pancreas transplantation, and application of chronopharmacokinetics to improve immunosuppression. Pharmacotherapy 1988; 8: 47–51
- Canafax D. M., Cipolle R. J., Hrushesky W. J. M., Rabatin J. T., Min D. I., Graves N. M., Sutherland D. E. R., Bowers L. D. The chronopharmacokinetics of cyclosporine and its metabolites in recipients of pancreas allografts. Transplant Proc 1988; 20: 471–477
- Venkataramanan R., Yang S., Burckart G. J., Ptachcinski R. J., Van Thiel D. H., Starzl T. E. Diurnal variation in cyclosporine kinetics. Ther Drug Monitor 1986; 8: 380–381
- Wagner O., Schreier E., Heitz F. Tissuedistribution, disposition, and metabolism of cyclosporine in rats. Drug Metab Dispos 1987; 15: 377–383
- Vadiei K., Brunner L. J., Luke D. R. Effects of isolation on renal function in rats. Breeder-specific. In press
- Luke D. R., Kasiske B. L., Matzke G. R., Awni W. A., Keane W. F. Effects of cyclosporine on the isolated perfused rat kidney. Transplantation 1987; 43: 795–799
- Iyer L., Vadiei K., Luke D. R. Cyclosporine pharmacokinetics and toxicity in two experimental models of diabetes. In press
- Marrino P., Gavish D., Shafrir E., Eisenberg S. Diurnal variations of plasma lipids, tissue and plasma lipoprotein lipase, and VLDL secretion rates in the rat. A model for studies of VLDL metabolism. Biochim Biophys Acta 1987; 920: 277–284
- Malmary M. F., Kabbaj K., Oustrin J. Circadian dosing-stage dependence in toxic and metabolic effects of ciclosporine. Presented at the 3rd International Congress on Chronopharmacology, Nice, FR,. 1988, Ann Rev Chronopharmacol. In press
- Shumak S. L., Zinman B., Zuniga-Guarjardo S., Poapst M., Steiner G. Triglyceride-rich lipoprotein metabolism during acute hyperinsulinemia in hypertriglyceridemic humans. Metabolism 1988; 37: 461–466
- Magnus G., Cavallini M., Halberg F., Cornelissen G., Sutherland D. E., Najarian J. A., Hrushesky W. J. Circadian toxicology of cyclosporin. Toxicol Appl Pharmacol 1985; 77: 181–185
- Pati A., Florentin I., Lemaigre G., Mechkouri M., Levi F. Chronopharmacologic optimization of oral ciclosporin A in mice: a search for a compromise between least renal toxicity and highest immunosuppressive activity. Presented at the 3rd International Congress on Chronopharmacology, Nice, FR,. 1988, Ann Rev Chronopharmacol. In press
- de Souza C. J., Meier A. H. Circadian and seasonal variations of plasma insulin and cortisol concentrations in the Syrian hamster,. Mesocricetus auratus. Chronobiol Int 1987; 4: 141–151